Showing results (31-40 of 217) with videos related to
Sort By:
Pageof 22
Nuclear Medicine Communications|April 26, 2016
Clinical significance of extraskeletal computed tomography findings on 18F-NaF PET/CT performed for osseous metastatic disease evaluationH Henry Guo, Farshad Moradi, Andrei IagaruTranslational Oncology|June 6, 2022
PSMA theragnostics for metastatic castration resistant prostate cancerHong Song, Kip E Guja, Andrei IagaruClinical Nuclear Medicine|January 23, 2018
Anaplastic Thyroid Cancer With Extensive Skeletal Muscle Metastases on 18F-FDG PET/CTIlana R Yurkiewicz, Kristen N Ganjoo, Andrei IagaruCurrent Opinion in Urology|July 24, 2020
Clinical application of Fluciclovine PET, choline PET and gastrin-releasing polypeptide receptor (bombesin) targeting PET in prostate cancerFrancesco Ceci, Paolo Castellucci, Giulia Polverari, et al.Seminars in Nuclear Medicine|March 3, 2024
Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PETKip E Guja, Kristen N Ganjoo, Andrei IagaruFrontiers in Nuclear Medicine|October 2, 2024
Mini review of first-in-human integrin αvβ6 PET tracersRichard H Kimura, Andrei Iagaru, H Henry GuoClinical Nuclear Medicine|August 22, 2007
F-18 FDG PET/CT in the management of thyroid cancerAndrei Iagaru, Judith E Kalinyak, I Ross McDougallHellenic Journal of Nuclear Medicine|March 31, 2009
Evaluation by 18F-FDG-PET of patients with anal squamous cell carcinomaAndrei Iagaru, Rabi Kundu, Hossein Jadvar, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 16, 2020
Imaging the Distribution of Gastrin-Releasing Peptide Receptors in CancerLucia Baratto, Heying Duan, Helmut Mäcke, et al.European Journal of Radiology|August 14, 2021
Prostate cancer: Molecular imaging and MRIFarshad Moradi, Andrea Farolfi, Stefano Fanti, et al.Pageof 22